Does intestinal dysbiosis contribute to an aberrant inflammatory response to SARS-CoV-2 in frail patients?

In few months, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become the main health worldwide problem. Epidemiological studies revealed that population has different vulnerability to SARS-CoV-2: severe outcome of COVID-19, with an increased risk of death, is observed in...

Full description

Autores:
Tipo de recurso:
Article of investigation
Fecha de publicación:
2020
Institución:
Universidad de Bogotá Jorge Tadeo Lozano
Repositorio:
Expeditio: repositorio UTadeo
Idioma:
eng
OAI Identifier:
oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12809
Acceso en línea:
https://doi.org/10.1016/j.nut.2020.110996
http://hdl.handle.net/20.500.12010/12809
Palabra clave:
SARS-CoV-2
COVID-19
Metabolic syndrome
Cardiovascular diseases
Gut dysbiosis
Nutraceuticals
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Rights
License
Acceso restringido